Cargando…
Intravesical botulinum toxin for lower urinary tract dysfunction
Botulinum neurotoxin has achieved substantial clinical benefits in neurogenic detrusor overactivity. More contentious has been its extension to management of refractory idiopathic detrusor overactivity, in which risk of impaired voiding function and consequent need for intermittent catheterisation m...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medicine Reports Ltd
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948404/ https://www.ncbi.nlm.nih.gov/pubmed/20948833 http://dx.doi.org/10.3410/M2-6 |